Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Condyloma Market size was valued at US$ 1,739.7 million in 2023 and is poised to grow at a significant CAGR of 5.1% from 2024-2030. Anogenital warts spurred on by the human papillomavirus (HPV) are referred to as condyloma acuminate and can affect both the male and female populations. Anogenital warts are most frequently carried on by HPV strains 6 and 11. Warts can develop anywhere near the vagina, cervix (in females), and scrotum, penis, groin, or thighs (in males). A double-stranded DNA virus called HPV is typically transmitted through intercourse.
Condyloma acuminata susceptibility is influenced by one's age, way of life, and sexual habits. Topical treatments include imiquimod cream, sinecatechins ointment, and solutions and creams containing podophyllotoxin. Other viable therapies include cryotherapy, trichloroacetic acid solution, and several surgical techniques. Following topical therapies, Condyloma acuminata has a possibility of returning. The only therapy with clearance rates close to 100% is surgical excision. Patients should be advised on available treatments, the value of follow-up visits, and safe sex procedures. With 9 to 13 percent of the world's population afflicted, HPV is the most prevalent sexually transmitted illness.
Most often, patients between the ages of 20 and 39 are impacted. Thus, with high prevalence, primarily in the young generation, the condyloma treatment market is predicted to grow in the presumption period. There are several identified risk factors for HPV infection.The likelihood of contracting an infection rises with more past sexual partners, a history of gonorrhea and chlamydia infections, smoking, and HIV infection. With around 10 million cigarettes sold worldwide and 36.9 million people living with HIV (including 1.8 million children), the chances of condyloma morbidity are to increase in the future, thus giving the thrust for the market growth. The occurrence of condyloma acuminata is challenging to predict since anogenital warts are not a disease that must be reported.
However, according to current estimates, there are 1.1 to 1.2 incidences of anogenital warts per 1000 people per year in the United States. Further, there are international level efforts by the World Health Organization to educate the population through an authoritarian level awareness campaign and eliminate sexually transmitted diseases by providing health care facilities and funds to the governments worldwide, which will drive the condyloma treatment market to flourish in the prognosticate span of the report. The major restrain for the market is the nonreporting of the disease. The disease prevalence is much higher than reported as this disease is typically nonlethal many infected patients never report it.
Study Period
2024– 2030Base Year
2023CAGR
5.1%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The prevalence of diseases caused by the Human Papilloma Virus is the most common kind of sexually transmitted disease worldwide. History of gonorrhea, Smoking, multiple sexual partners, and the presence of HIV infection is the main cause of the disease to spread worldwide. Thus, with the increase in etiology of the disease in modern society, the condyloma treatment demand either in pharmacological or surgical methods or in another advanced technological way (cryotherapy) is about to multiply. Thus, the condyloma market report by Precision Business Insights picturizes the market growth in the forecast period at a constant CAGR of 5.1%.
Report Benchmarks |
Details |
Report Study Period |
2024– 2030 |
Market Size in 2023 |
US$ 1,739.7 million |
Market CAGR |
5.1% |
By Treatment |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global condyloma market size was valued at US$ 312.6 million in 2023 and is projected to grow at a CAGR of 4.8% from 2024 to 2030.
Perrigo Company plc, Novartis AG, Merck & Co. Inc., Emblation Ltd., Verrica Pharmaceuticals, Novan, Inc., GlaxoSmithKline plc., Pfizer Inc., Mylan N.V.
Asia Pacific is the fastest-growing region for the condyloma market
1. Executive Summary |
2. Global Condyloma Market Introduction |
2.1. Global Condyloma Market - Taxonomy |
2.2. Global Condyloma Market -Definitions |
2.2.1. By Treatment |
2.2.2. By End User |
2.2.3. By Region |
3. Global Condyloma Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Condyloma Market Dynamic Factors - Impact Analysis |
3.6. Global Condyloma Market - Competition Landscape |
3.7. Epidemiology |
4. Global Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Condyloma Market, By Treatment, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Prescription Drugs |
5.1.1. Imiquimod |
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Podophyllin and Podofilox |
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Trichloroacetic Acid |
5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Sinecatechins |
5.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.1.5. Others |
5.1.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.5.3. Market Opportunity Analysis |
5.2. Surgery |
5.2.1. Cryotherapy |
5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Electrocautery |
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Surgical Excision |
5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.2.4. Laser Treatments |
5.2.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
5.2.5. Others |
5.2.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.5.3. Market Opportunity Analysis |
6. Global Condyloma Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Hospitals |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Retail Pharmacies |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Online Pharmacies |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Condyloma Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Region, 2024 - 2030 |
8. North America Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Prescription Drugs |
8.1.1.1. Imiquimod |
8.1.1.2. Podophyllin and Podofilox |
8.1.1.3. Trichloroacetic Acid |
8.1.1.4. Sinecatechins |
8.1.1.5. Others |
8.1.2. Surgery |
8.1.2.1. Cryotherapy |
8.1.2.2. Electrocautery |
8.1.2.3. Surgical Excision |
8.1.2.4. Laser Treatments |
8.1.2.5. Others |
8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Hospitals |
8.2.2. Retail Pharmacies |
8.2.3. Online Pharmacies |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030 |
8.5. North America Condyloma Market Dynamics - Trends |
9. Europe Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Prescription Drugs |
9.1.1.1. Imiquimod |
9.1.1.2. Podophyllin and Podofilox |
9.1.1.3. Trichloroacetic Acid |
9.1.1.4. Sinecatechins |
9.1.1.5. Others |
9.1.2. Surgery |
9.1.2.1. Cryotherapy |
9.1.2.2. Electrocautery |
9.1.2.3. Surgical Excision |
9.1.2.4. Laser Treatments |
9.1.2.5. Others |
9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Hospitals |
9.2.2. Retail Pharmacies |
9.2.3. Online Pharmacies |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Rest of Europe |
9.4. Europe Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030 |
9.5. Europe Condyloma Market Dynamics - Trends |
10. Asia-Pacific Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Prescription Drugs |
10.1.1.1. Imiquimod |
10.1.1.2. Podophyllin and Podofilox |
10.1.1.3. Trichloroacetic Acid |
10.1.1.4. Sinecatechins |
10.1.1.5. Others |
10.1.2. Surgery |
10.1.2.1. Cryotherapy |
10.1.2.2. Electrocautery |
10.1.2.3. Surgical Excision |
10.1.2.4. Laser Treatments |
10.1.2.5. Others |
10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Hospitals |
10.2.2. Retail Pharmacies |
10.2.3. Online Pharmacies |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. China |
10.3.2. India |
10.3.3. Japan |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030 |
10.5. Asia-Pacific Condyloma Market Dynamics - Trends |
11. Latin America Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Prescription Drugs |
11.1.1.1. Imiquimod |
11.1.1.2. Podophyllin and Podofilox |
11.1.1.3. Trichloroacetic Acid |
11.1.1.4. Sinecatechins |
11.1.1.5. Others |
11.1.2. Surgery |
11.1.2.1. Cryotherapy |
11.1.2.2. Electrocautery |
11.1.2.3. Surgical Excision |
11.1.2.4. Laser Treatments |
11.1.2.5. Others |
11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Hospitals |
11.2.2. Retail Pharmacies |
11.2.3. Online Pharmacies |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030 |
11.5. Latin America Condyloma Market Dynamics - Trends |
12. Middle East and Africa Condyloma Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Prescription Drugs |
12.1.1.1. Imiquimod |
12.1.1.2. Podophyllin and Podofilox |
12.1.1.3. Trichloroacetic Acid |
12.1.1.4. Sinecatechins |
12.1.1.5. Others |
12.1.2. Surgery |
12.1.2.1. Cryotherapy |
12.1.2.2. Electrocautery |
12.1.2.3. Surgical Excision |
12.1.2.4. Laser Treatments |
12.1.2.5. Others |
12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Hospitals |
12.2.2. Retail Pharmacies |
12.2.3. Online Pharmacies |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Condyloma Market - Opportunity Analysis Index, By Treatment, By End User, and Country, 2024 - 2030 |
12.5. MEA Condyloma Market Dynamics - Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Bausch Health Companies Inc. |
13.2.2. Graceway Pharmaceuticals |
13.2.3. Glenmark |
13.2.4. Allergan |
13.2.5. Teva Pharmaceutical Industries Ltd. |
13.2.6. Perrigo Company plc |
13.2.7. Novartis AG |
13.2.8. Merck & Co. Inc. |
13.2.9. Emblation Ltd. |
13.2.10. Verrica Pharmaceuticals |
13.2.11. Novan, Inc. |
13.2.12. GlaxoSmithKline plc. |
13.2.13. Pfizer Inc. |
13.2.14. Mylan N.V. |
13.2.15. Taro Pharmaceutical Industries Ltd. |
13.2.16. Cipla Ltd. |
13.2.17. Phio Pharmaceuticals Corp. |
13.2.18. Prestige Consumer Healthcare Inc. |
13.2.19. AIM ImmunoTech, Inc. |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players